Dimension not matched!

D e l i v e r   H o p e   f o r   a   B e t t e r   L i f e



  • 05 USPTO provisional application (application No.: 62667889 and 62670875)


  • 10 Funded by MOEA Government grant
  • 07 USPTO provisional application (application No.: 62536034 and 62595207)


  • 10 Renamed “國邑藥品科技股份有限公司” / “Pharmosa Biopharm Inc.”
  • 10 Re-location of headquarters to Taipei City
  • 05 Focusing on new drug development through the 505(b)2 pathway


Pharmosa Limited (a predecessor of Pharmosa Biopharm Inc.)

  • Recognized as a "Biotech and New Drug Company" by the Taiwanese government
  • Licensing most Gx Products to Anxo Pharma
  • M480384 patent granted in Taiwan and China
  • 2010, Setup of R&D Center in Nankang, Taipei
  • 2000, Pharmosa Limited founded in Taichung.